Get started
Author

Courtney H. Coschi

Observed names: Coschi, Courtney H, Coschi, Courtney H., Courtney Coschi, Courtney H Coschi
Institution: McMaster University
Observed institutions: Western University, Queen's University, Juravinski Cancer Centre, Children’s Health Research Institute, Canadian Cancer Trials Group, Hamilton Health Sciences, McMaster University
ORCID: 0000-0002-3421-3878
Observed ORCID: 0000-0002-3421-3878
OpenAlex ID: A5020164050
Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive
2010 · Courtney H. Coschi, Alison L. Martens, et al. · Genes & Development · 128
PDF
Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
2014 · Courtney H. Coschi, Charles A. Ishak, et al. · Cancer Discovery · 82
Chromosome instability and deregulated proliferation: an unavoidable duo
2012 · Courtney H. Coschi, Frederick A. Dick · Cellular and Molecular Life Sciences · 39
A Functional Connection between pRB and Transforming Growth Factor β in Growth Inhibition and Mammary Gland Development
2009 · Sarah M. Francis, Jacqueline Bergsied, et al. · Molecular and Cellular Biology · 26
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)
2023 · Maria Carmela Piccirillo, Quincy Chu, et al. · Journal of Thoracic Oncology · 21
PDF
Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment
2017 · Charles A. Ishak, Courtney H. Coschi, et al. · Cell Cycle · 19
PDF
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response
2023 · Courtney H. Coschi, Rosalyn A. Juergens · Current Oncology · 18
PDF
A Narrative Review of the Strengths and Limitations of Real-World Evidence in Comparison to Randomized Clinical Trials: What Are the Opportunities in Thoracic Oncology for Real-World Evidence to Shine?
2025 · Peter M. Ellis, Larissa Long, et al. · Current Oncology · 11
PDF
Understanding the Attitudes and Beliefs of Oncologists Regarding the Transitioning and Sharing of Survivorship Care
2021 · Courtney H. Coschi, Daryl Bainbridge, et al. · Current Oncology · 9
PDF
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
2025 · Jan Rekowski, Christina Guo, et al. · EClinicalMedicine · 7
PDF
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
2021 · Courtney H. Coschi, Rosalyn A. Juergens · Current Oncology · 7
PDF
Cell Synchronization of Mouse Embryonic Fibroblasts
2015 · Michael J. Thwaites, Courtney H. Coschi, et al. · Methods in molecular biology · 6
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
2025 · Moreno Ursino, Guillermo Villacampa, et al. · EClinicalMedicine · 5
Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen
2025 · Zainab Al Maqrashi, Michelle Bradbury, et al. · Future Science OA · 3
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
2025 · Courtney H. Coschi, Keyue Ding, et al. · Immunotherapy · 3
PDF
Oncology: What You May Have Missed in 2023
2024 · Courtney H. Coschi, Lorin Dodbiba, et al. · Annals of Internal Medicine · 2
Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies
2023 · Shahistha Sayeda, Asghar Naqvi, et al. · Cureus · 2
PDF
IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.
2025 · David W. Cescon, Moira Rushton, et al. · Journal of Clinical Oncology · 1
Feasibility of Patient- and Caregiver-Reported Outcome Measures in Incurable Cancer: Implications for Early Palliative Care Communication
2026 · Hsien Seow, Daryl Bainbridge, et al. · Journal of Clinical Medicine
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
2025 · Courtney H Coschi, Keyue Ding, et al. · Immunotherapy
Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: another weapon in the armamentarium
2025 · Courtney H. Coschi, Peter M. Ellis · Journal of Thoracic Disease
Abstract CT239: IND.241: A Canadian cancer trials group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast cancer
2025 · Moira Rushton, Dave W. Cescon, et al. · Cancer Research
Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813–819]”
2024 · Maria Carmela Piccirillo, Quincy Chu, et al. · Journal of Thoracic Oncology
PDF
A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).
2023 · Peter Michael Ellis, Sara Kristina Taylor, et al. · Journal of Clinical Oncology
Supplementary Methods from Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
2023 · Courtney H. Coschi, Charles A. Ishak, et al.
Works count: 36
Citation count: 390
H-index: 9
I10-index: 8
Year
Topic
Type